DYNLL2 Antikörper
-
- Target Alle DYNLL2 Antikörper anzeigen
- DYNLL2 (Dynein, Light Chain, LC8-Type 2 (DYNLL2))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DYNLL2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Full length fusion protein
- Isotyp
- IgG
- Top Product
- Discover our top product DYNLL2 Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000, ELISA 1:2000-1:5000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.7 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- DYNLL2 (Dynein, Light Chain, LC8-Type 2 (DYNLL2))
- Andere Bezeichnung
- DYNLL2 (DYNLL2 Produkte)
- Synonyme
- DNCL1B antikoerper, Dlc2 antikoerper, RSPH22 antikoerper, dlc2 antikoerper, dncl1b antikoerper, 1700064A15Rik antikoerper, 6720463E02Rik antikoerper, C87222 antikoerper, DLC8 antikoerper, DLC8b antikoerper, dynein light chain LC8-type 2 antikoerper, dynein light chain LC8-type 2 S homeolog antikoerper, DYNLL2 antikoerper, dynll2.S antikoerper, dynll2 antikoerper, Dynll2 antikoerper
- Hintergrund
- Dynein light chain 2, cytoplasmicis aproteinthat in humans is encoded by theDYNLL2gene. Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules.
- Molekulargewicht
-
Observed_MW: Refer to figures
Calculated_MW: 10 kDa
- UniProt
- Q96FJ2
- Pathways
- M Phase
-